Nov 10, 2017 21:31 pm UTC| Business
LAS VEGAS, Nov. 10, 2017 -- Several members from Trusted LASIK Surgeons™ will be presenting the latest in ophthalmological techniques and research at the 2017 American Academy of Ophthalmology (AAO) Annual Meeting to be...
Cornerstone Funds Announce Continuing Monthly Distributions and Reset Distribution Amounts for 2018
Nov 10, 2017 21:30 pm UTC| Business
NEW YORK, Nov. 10, 2017 -- Cornerstone Strategic Value Fund, Inc. (NYSE American:CLM) and Cornerstone Total Return Fund, Inc. (NYSE American:CRF), (individually the “Fund” or, collectively, the “Funds”), each a...
Trisura Group Reports Third Quarter 2017 Results
Nov 10, 2017 21:30 pm UTC| Business
TORONTO, Nov. 10, 2017 -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX:TSU) today announced financial results for the quarter ended September 30, 2017. "Trisura had an excellent quarter with strong premium...
Jumei Selects E&Y as its Independent Registered Public Accounting Firm
Nov 10, 2017 21:30 pm UTC| Business
BEIJING, Nov. 10, 2017 -- Jumei International Holding Limited (NYSE:JMEI) (“Jumei” or the “Company”) announced that, effective as of November 07, 2017, the Company engaged Ernst Young Hua Ming LLP (“EY”) as the...
CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
Nov 10, 2017 21:15 pm UTC| Business
IRVINE, Calif., Nov. 10, 2017 -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing...
ZIOPHARM to Present at the Stifel 2017 Healthcare Conference
Nov 10, 2017 21:05 pm UTC| Business
BOSTON, Nov. 10, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that David Mauney, M.D., CBO and interim COO, will present at the Stifel 2017 Healthcare Conference in New York on Tuesday, November 14,...
Voyager Therapeutics Announces Closing of Public Offering of Common Stock
Nov 10, 2017 21:05 pm UTC| Business
CAMBRIDGE, Mass., Nov. 10, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update